Open AccessNew Drug Review-Ezogabine (Potiga): Seizing the seizure
Author(s) -
Misty L. Gonzalez
Publication year - 2011
Publication title -
mental health clinician
Language(s) - English
Resource type - Journals
ISSN - 2168-9709
DOI - 10.9740/mhc.n89803
Subject(s) - food and drug administration , medicine , drug , adverse effect , clinical trial , new drug application , approved drug , pharmacology , intensive care medicine
Ezogabine was approved by the Food and Drug Administration (FDA) in June of 2011. This article reviews clinically significant aspects of this new drug including: the FDA-approved indications, mechanism of action, administration, drug interactions, adverse effects, clinical trial evidence, innovative properties and place in therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom